PA
ANAC

Perceptive Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Perceptive Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-528,776
Closed -$9.38M – 163
2014
Q2 		$9.38M Sell
528,776
-118,239
-18% -$1.9M 0.92% 33
2014
Q1 		$12.9M Buy
647,015
+159,473
+33% +$3.09M 1.36% 22
2013
Q4 		$8.18M Sell
487,542
-486,326
-50% -$6.73M 0.98% 24
2013
Q3 		$10.3M Buy
973,868
+391,033
+67% +$3.42M 0.84% 28
2013
Q2 		$3.26M Buy
+582,835
New +$3.53M 0.33% 41

Other funds holding ANAC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's ANAC Position: Q3 2014 in Review

Perceptive Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2014, closing a stake of 528,776 shares — an estimated $9.38M sold.

Perceptive Advisors first reported a position in ANAC in Q2 2013 and held it in 5 quarters. The position peaked at $12.9M in Q1 2014. 116 funds tracked by Wall St. Rank hold ANAC as of Q3 2014.

  • Perceptive Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2014 after selling out during the quarter.
  • Perceptive Advisors sold 528,776 ANACOR PHARMACEUTICALS INC COM shares in Q3 2014, an estimated $9.38M.
  • Perceptive Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 5 quarters.
  • Perceptive Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $12.9M in Q1 2014.
  • 116 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2014.

Based on Perceptive Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.